Cargando…
Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India
PURPOSE: Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it. MATERIALS AND METHODS: This was a retrospective observational study. All the protoc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345254/ https://www.ncbi.nlm.nih.gov/pubmed/35928639 http://dx.doi.org/10.4103/picr.PICR_124_20 |
_version_ | 1784761378433662976 |
---|---|
author | Kalikar, Mrunalini V. Dakhale, Ganesh N. Sinha, Vishakha V. Giradkar, Akhil B. |
author_facet | Kalikar, Mrunalini V. Dakhale, Ganesh N. Sinha, Vishakha V. Giradkar, Akhil B. |
author_sort | Kalikar, Mrunalini V. |
collection | PubMed |
description | PURPOSE: Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it. MATERIALS AND METHODS: This was a retrospective observational study. All the protocols for regulatory clinical trials and academic research sponsored by the Indian Council of Medical Research or other funding agency were included. Insurance documents and CTA submitted with the study protocols were analyzed. RESULTS: A total of seventy CTA and insurance policies were analyzed. CTA mentioned that parties involved in 60 (86%) forms, scope of the agreement in 15 (21%) forms, responsibilities of the party in 68 (97%) forms, and payment details in 58 (83%) forms. Nearly 88.5% of the insurance policies mentioned whether the policy covers the participants for injury due to all clauses and 91% of the policies mentioned the validity period of insurance. CONCLUSION: It was found that both the documents contained almost all the required elements. This was probably because this institutional EC insisted on and thoroughly reviewed the documents to ensure that adequate compensation of research-related injuries has been provided for and this fact is informed to the trial subject. As very few studies are available in the literature, we could not compare majority of the findings of this study with others. |
format | Online Article Text |
id | pubmed-9345254 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-93452542022-08-03 Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India Kalikar, Mrunalini V. Dakhale, Ganesh N. Sinha, Vishakha V. Giradkar, Akhil B. Perspect Clin Res Original Article PURPOSE: Very few studies conducted in India have analyzed insurance policies and clinical trial agreement (CTA) submitted to ethics committee (EC). This study was conducted to review and find out deficiencies in it. MATERIALS AND METHODS: This was a retrospective observational study. All the protocols for regulatory clinical trials and academic research sponsored by the Indian Council of Medical Research or other funding agency were included. Insurance documents and CTA submitted with the study protocols were analyzed. RESULTS: A total of seventy CTA and insurance policies were analyzed. CTA mentioned that parties involved in 60 (86%) forms, scope of the agreement in 15 (21%) forms, responsibilities of the party in 68 (97%) forms, and payment details in 58 (83%) forms. Nearly 88.5% of the insurance policies mentioned whether the policy covers the participants for injury due to all clauses and 91% of the policies mentioned the validity period of insurance. CONCLUSION: It was found that both the documents contained almost all the required elements. This was probably because this institutional EC insisted on and thoroughly reviewed the documents to ensure that adequate compensation of research-related injuries has been provided for and this fact is informed to the trial subject. As very few studies are available in the literature, we could not compare majority of the findings of this study with others. Wolters Kluwer - Medknow 2022 2021-03-26 /pmc/articles/PMC9345254/ /pubmed/35928639 http://dx.doi.org/10.4103/picr.PICR_124_20 Text en Copyright: © 2021 Perspectives in Clinical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Kalikar, Mrunalini V. Dakhale, Ganesh N. Sinha, Vishakha V. Giradkar, Akhil B. Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India |
title | Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India |
title_full | Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India |
title_fullStr | Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India |
title_full_unstemmed | Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India |
title_short | Analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central India |
title_sort | analysis of clinical trial agreement and insurance policy submitted to the ethics committee of a tertiary care teaching institute in central india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345254/ https://www.ncbi.nlm.nih.gov/pubmed/35928639 http://dx.doi.org/10.4103/picr.PICR_124_20 |
work_keys_str_mv | AT kalikarmrunaliniv analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia AT dakhaleganeshn analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia AT sinhavishakhav analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia AT giradkarakhilb analysisofclinicaltrialagreementandinsurancepolicysubmittedtotheethicscommitteeofatertiarycareteachinginstituteincentralindia |